A life science venture investor is merging two of its biotechnology portfolio companies to form a single developer of nanoscale medications with programmable properties. . . . → Read More: Merger to Form Programmable Nano-Medicines Company
|
|||||
       |
 Comments are closed  Finance, New products  biomedical, biotechnology, chemistry, engineering, entrepreneurs, genomics, investment, life sciences, merger, nanotechnology, pharmaceuticals, physical sciences, venture capital 
The value of mergers and acquisitions in the global technology sector rose for the first time in over a year in the second quarter of 2023, while M&A deal counts dropped somewhat. . . . → Read More: Infographic – Q2 Tech Merger Values Up, Deals Down Comments are closed Finance biotechnology, engineering, equity, investment, mathematics, merger, robotics, software, statistics 
Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders. . . . → Read More: Regeneron Acquires Hearing Loss Biotech in $213M Deal Comments are closed Finance, New products biomedical, biotechnology, clinical trials, genomics, investment, life sciences, merger, pharmaceuticals, university 
Two companies using artificial intelligence to advance biotechnology and design new therapies are merging with a computational-engineering drug discovery enterprise. . . . → Read More: Computational Drug Discovery Company Acquires A.I. Businesses Comments are closed Finance biomedical, biotechnology, Canada, chemistry, computer science, engineering, equity, genomics, investment, life sciences, mathematics, merger, pharmaceuticals, physical sciences, university 
Two providers of technologies for cellular analysis are merging to form a new company focusing on cell biology research tools, in a sign of continued industry consolidation. . . . → Read More: Cell Biology Tools Companies Merge in $57.8M Deal Comments are closed Finance biomedical, biotechnology, chemistry, engineering, equity, investment, life sciences, merger, physical sciences 
Two developers of virtual reality therapy technology for mental health disorders are combining their operations, and raising $13 million in venture funds. . . . → Read More: Mental Health VR Companies Merge, Raise $13M Comments are closed Finance, New products behavioral science, biomedical, clinical trials, engineering, entrepreneurs, equity, investment, life sciences, medical device, merger, psychiatric, software, U.K., university, venture capital 
(Myriams-Fotos, Pixabay. https://pixabay.com/photos/milk-splash-drops-food-liquid-4755234/) 31 Oct. 2022. A developer of synthetic biology treatments for inflammatory and neurological disorders linked to the gut is becoming a public company through a special acquisition merger. Intrinsic Medicine Inc. in Seattle is joining with Phoenix Biotech Acquisition Corp. in Oakland, California, a special purpose acquisition company or SPAC, . . . → Read More: Gut-Brain Meds Developer Going Public in Merger Comments are closed Finance biomedical, biotechnology, clinical trials, entrepreneurs, equity, investment, IPO, life sciences, merger, pharmaceuticals, preclinical 
A biotechnology developer of treatments for autoimmune disorders with checkpoint receptor proteins is acquired by drug maker Gilead Sciences. . . . → Read More: Immune Disease Biotech Acquired in $405M Deal One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, life sciences, merger, pharmaceuticals, physical sciences, U.K., university 
A developer of synthetic biology tools and components is acquiring a biological materials developer for its automation assets as the biotechnology industry consolidates. . . . → Read More: Ginkgo Acquires Biomaterials Maker as Industry Consolidates 
A developer of therapies derived from stem cells to replace malfunctioning islet cells in people with type 1 diabetes was acquired by Vertex Pharmaceuticals. . . . → Read More: Diabetes Cell Therapy Biotech Acquired in $320M Deal Comments are closed Finance, New products biomedical, biotechnology, equity, genomics, investment, life sciences, merger, pharmaceuticals, stem cells |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.